Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02329782 · ClinicalTrials.gov registry record · NA
Supporting Treatment Adherence Readiness Through Training (START)
A NA study of HIV Medication Adherence, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 3
- Study locations
NCT02329782 is a NA study of HIV Medication Adherence that has completed, run by RAND. The registered enrollment target is 240 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT02329782, a NA study of HIV Medication Adherence, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 3
- Study locations
Study Summary
Multi-site, randomized controlled trial of the Adherence Readiness Program (ARP) adherence intervention for HIV clients starting or restarting antiretroviral therapy (ART) for the purpose of achieving and sustaining optimal levels of ART adherence and virologic suppression. Eligible participants will be randomized to receive either the ARP intervention or usual care (no intervention) and followed for 24 months.
Conditions Studied
Interventions
- BEHAVIORAL Adherence Readiness Program
Study Locations (3)
California
- CARE CLinic - Long Beach
- T.H.E. Clinic - Los Angeles
- UCLA Care Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2015-02 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02329782
The ClinicalTrials.gov registry entry for NCT02329782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Adherence Readiness Program is the first listed.
NCT02329782 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02329782 about?
NCT02329782 is a clinical study titled "Supporting Treatment Adherence Readiness Through Training (START)". Multi-site, randomized controlled trial of the Adherence Readiness Program (ARP) adherence intervention for HIV clients starting or restarting antiretroviral therapy (ART) for the purpose of achieving and sustaining optimal levels of ART adherence and virologic suppression. Eligible participants wil...
What is the current status of trial NCT02329782?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2015-02. Estimated completion is 2020-03-30.
What conditions does trial NCT02329782 study?
This clinical trial studies the following conditions: HIV Medication Adherence.
What interventions are being tested in trial NCT02329782?
The interventions under investigation include: Adherence Readiness Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02329782?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02329782 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.